HIV-1 antiviral behavior of anionic PPI metallo-dendrimers with EDA core

European Journal of Medicinal Chemistry

Volumn 98, Issue , 2015, Pages 139-148

  García Gallego, Sandra ^a,b,d   Díaz, Laura ^b,c   Jiménez, José Luis ^b,c   Gómez, Rafael ^a,b   De La Mata, F Javier ^a,b   Muñoz Fernández, M Ángeles ^b,c  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Carboxylate; Dendrimer; HIV; Sulfonate; Transition metal

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COBALT COMPLEX; COPPER COMPLEX; DENDRIMER; ENFUVIRTIDE; ETHYLENEDIAMINE; GALACTOSYLCERAMIDE; NICKEL COMPLEX; PLERIXAFOR; POLY(PROPYLENEIMINE); POLYPROPYLENE; SURAMIN; TENOFOVIR; UNCLASSIFIED DRUG; ZINC COMPLEX; ANION; METAL;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BIOCOMPATIBILITY; CARBOXYLATION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; INTERNALIZATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SULFONATION; TROPISM; VIRUS ENTRY; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS STRAIN; CHEMISTRY; DRUG EFFECTS;

ANIONS; ANTI-HIV AGENTS; DENDRIMERS; HIV-1; HUMANS; METALS; POLYPROPYLENES;

EID: 84929990934     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2015.05.026     Document Type: Article

References (51)

1. C. Vanpouille, A. Arakelyan, L. Margolis, Microbicides: still a long road to success, Trends Microbiol. 20 (2012) 369-375.
2. S.-H. Hwang, C.D. Shreiner, C.N. Moorefield, G.R. Newkome, Recent progress and applications for metallodendrimers, New. J. Chem. 31 (2007) 1192-1217.
3. V. Simon, D.D. Ho, Q. Abdool Karim, HIV/AIDS epidemiology, pathogenesis, prevention, and treatment, Lancet 368 (2006) 489-504.
4. UNAIDS, Global Report: UNAIDS Report on the Global AIDS Epidemic 2012, Joint United Nations Programme on HIV/AIDS and World Health Organisation (WHO), Geneva, Switzerland, 2012.
5. V. Buffa, K. Klein, L. Fischetti, R.J. Shattock, Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice, PLoS One 7 (2012) 1-10.
6. W.C. Koff, HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem, Vaccine 30 (2012) 4310-4315.
7. Y. Nishiyama, S. Planque, C.V. Hanson, R.J. Massey, S. Paul, CD4 binding determinant mimicry for HIV vaccine design, Front. Immunol. 3 (2012) 1-13.
8. A.A. Date, A. Shibata, M. Goede, B. Sanford, K. La Bruzzo, M. Belshan, C.J. Destache, Development and evaluation of a thermosensitive vaginal gel containing raltegravir + efavirenz loaded nanoparticles for HIV prophylaxis, Antivir. Res. 96 (2012) 430-436.
9. D. Sepúlveda-Crespo, R. Lorente, M. Leal, R. Gomez, F.J. de la Mata, J.L. Jimenez, M.A. Muñoz-Fernandez, Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide, Nanomedicine 10 (2014) 609-618.
10. B.F. Haynes, D.C. Montefiori, Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates, Expert Rev. Vaccines 5 (2006) 579-595.
11. A. Rosa Borges, C.L. Schengrund, Dendrimers and antivirals: a review, Curr. Drug Targets Infect. Disord. 5 (2005) 247-254.
12. A. Bernardi, J. Jimenez-Barbero, A. Casnati, C. De Castro, T. Darbre, F. Fieschi, J. Finne, H. Funken, K.-E. Jaeger, M. Lahmann, T.K. Lindhorst, M. Marradi, P. Messner, A. Molinaro, P.V. Murphy, C. Nativi, S. Oscarson, S. Penades, F. Peri, R.J. Pieters, O. Renaudet, J.-L. Reymond, B. Richichi, J. Rojo, F. Sansone, C. Schaffer, W.B. Turnbull, T. Velasco-Torrijos, S. Vidal, S. Vincent, T. Wennekes, H. Zuilhof, A. Imberty, Multivalent glycoconjugates as antipathogenic agents, Chem. Soc. Rev. 42 (2013) 4709-4727.
13. G.R. Newkome, C.N. Moorefield, F. Vögtle, Dendrimers and Dendrons, second ed., Wiley-VCH, New York, Weinheim, 2001, p. 635.
14. M. Blanzat, C.-O. Turrin, E. Perez, I. Rico-Lattes, A.-M. Caminade, J.-P. Majoral, Phosphorus-containing dendrimers bearing galactosylceramide analogs: selfassembly properties, Chem. Commun. (2002) 1864-1865.
15. M. Blanzat, C.-O. Turrin, A.-M. Aubertin, C. Couturier-Vidal, A.-M. Caminade, J.-P. Majoral, I. Rico-Lattes, A. Lattes, Dendritic catanionic assemblies: in vitro anti-HIV activity of phosphorus-containing dendrimers bearing Galb1cer analogues, ChemBioChem 6 (2005) 2207-2213.
16. A. Perez-Anes, C. Stefaniu, C. Moog, J.-P. Majoral, M. Blanzat, C.-O. Turrin, A.-M. Caminade, I. Rico-Lattes, Multivalent catanionic GalCer analogs derived from first generation dendrimeric phosphonic acids, Bioorg. Med. Chem. 18 (2010) 242-248.
17. A. Rosa Borges, L. Wieczorek, B. Johnson, A.J. Benesi, B.K. Brown, R.D. Kensinger, F.C. Krebs, B. Wigdahl, R. Blumenthal, A. Puri, F.E. McCutchan, D.L. Birx, V.R. Polonis, C.-L. Schengrund, Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1, Virology 408 (2010) 80-88.
18. J.-F. Nierengarten, J. Iehl, V. Oerthel, M. Holler, B.M. Illescas, A. Munoz, N. Martin, J. Rojo, M. Sanchez-Navarro, S. Cecioni, S. Vidal, K. Buffet, M. Durka, S.P. Vincent, Fullerene sugar balls, Chem. Commun. 46 (2010) 3860-3862.
19. J. Luczkowiak, A. Muñoz, M. Sanchez-Navarro, R. Ribeiro-Viana, A. Ginieis, B.M. Illescas, N. Martín, R. Delgado, J. Rojo, Glycofullerenes inhibit viral infection, Biomacromolecules 14 (2013) 431-437.
20. J. Fantini, N. Yahi, K. Mabrouk, J. Van Rietschoten, H. Rochat, J.M. Sabatier, Multi-branched peptides based on the HIV-1 V3 loop consensus motif inhibit HIV-1 and HIV-2 infection in CD4+ and CD4-cells, C. R. Acad. Sci. Ser. III 316 (1993) 1381-1387.
21. O. Delezay, D. Hammache, J. Fantini, N. Yahi, SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids, Biochemistry 35 (1996) 15663-15671.
22. N. Yahi, J. Fantini, S. Baghidiguian, K. Mabrouk, C. Tamalet, H. Rochat, J. van Rietschoten, J.-M. Sabatier, SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4 cells by two distinct mechanisms, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4867-4871.
23. E. De Clercq, Antiviral therapy for human immunodeficiency virus infections, Clin. Microbiol. Rev. 8 (1995) 200-239.
24. Matthews B.R., Holan G, Antiviral Polyamidoamine Dendrimers, WO9534595A1, 1995.
25. M. Witvrouw, V. Fikkert, W. Pluymers, B. Matthews, K. Mardel, D. Schols, J. Raff, Z. Debyser, E. De Clercq, G. Holan, C. Pannecouque, Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle, Mol. Pharmacol. 58 (2000) 1100-1108.
26. D.W. Dixon, A.F. Gill, L. Giribabu, A.N. Vzorov, A.B. Alam, R.W. Compans, Sulfonated naphthyl porphyrins as agents against HIV-1, J. Inorg. Biochem. 99 (2005) 813-821.
27. R. Rupp, S.L. Rosenthal, L.R. Stanberry, VivaGel (SPL7013 Gel): a candidate dendrimer-microbicide for the prevention of HIV and HSV infection, Int. J. Nanomed. 2 (2007) 561-566.
28. de la Mata F.J., Gomez R., Muñoz-Fernandez M.A., Sanchez-Nieves J., Ortega P., Chonco L., Rasines B., Arnaiz E., Serramía M.J., Carbosilane Dendrimers and the Use thereof as Antiviral Agentes, WO2011101520, 2011.
29. B. Rasines, J. Sanchez-Nieves, M. Maiolo, M. Maly, L. Chonco, J.L. Jimenez, M.A. Muñoz-Fernandez, F.J. de la Mata, R. Gomez, Synthesis, structure and molecular modelling of anionic carbosilane dendrimers, Dalton Trans. 41 (2012) 12733-12748.
30. E. Vacas-Cordoba, E. Arnaiz, M. Relloso, C. Sanchez-Torres, F. García, L. Perez-Alvarez, R. Gomez, F.J. de la Mata, M. Pion, M.A. Muñoz-Fernandez, Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission, AIDS 27 (2013) 1219-1229.
31. E. Vacas-Cordoba, E. Arnaiz, F.J. de la Mata, R. Gomez, M. Leal, M. Pion, M.A. Muñoz-Fernandez, Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro, AIDS 27 (2013) 2053-2058.
32. E. Arnaiz, E. Vacas-Cordoba, M. Galan, M. Pion, R. Gomez, M.A. Muñoz-Fernandez, F.J. de la Mata, Synthesis of anionic carbosilane dendrimers via "click chemistry" and their antiviral properties against HIV, J. Polym. Sci. Part A: Polym. Chem. 52 (2014) 1099-1112.
33. M. Galan, J. Sanchez Rodríguez, J.L. Jimenez, M. Relloso, M. Maly, F.J. de la Mata, M.A. Muñoz-Fernandez, R. Gomez, Synthesis of new anionic carbosilane dendrimers via thiol-ene chemistry and their antiviral behaviour, Org. Biomol. Chem. 12 (2014) 3222-3237.
34. R.D. Kensinger, B.J. Catalone, F.C. Krebs, B. Wigdahl, C.-L. Schengrund, Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection, Antimicrob. Agents Chemother. 48 (2004) 1614-1623.
35. S. Han, Y. Dai, T. Kanamoto, H. Nakashima, T. Uryu, T. Yoshida, Sulfated oligosaccharide cluster with polylysine core scaffold as a new anti-HIV dendrimer, Carbohydr. Polym. 80 (2010) 1111-1115.
36. W. Kowalczyk, A. Mascaraque, M. Sanchez-Navarro, J. Rojo, D. Andreu, Convergent synthesis of glycodendropeptides by click chemistry approaches, Eur. J. Org. Chem. 2012 (2012) 4565-4573.
37. P. Govender, B. Therrien, G.S. Smith, Bio-metallodendrimers: emerging therapeutics in metal-based drug design, Eur. J. Inorg. Chem. 17 (2012) 2853-2862.
38. G.R. Newkome, E. He, C.N. Moorefield, Suprasupermolecules with novel properties: metallodendrimers, Chem. Rev. Wash. D. C. 99 (1999) 1689-1746.
39. D. Astruc, C. Ornelas, J. Ruiz, Metallocenyl dendrimers and their applications in molecular electronics, sensing, and catalysis, Acc. Chem. Res. 41 (2008) 841-856.
40. D. Astruc, M.-C. Daniel, J. Ruiz, Dendrimers and gold nanoparticles as exoreceptors sensing biologically important anions, Chem. Commun. (2004) 2637-2649.
41. L. Xu, L.-J. Chen, H.-B. Yang, Recent progress in the construction of cavitycored supramolecular metallodendrimers via coordination-driven self-Assembly, Chem. Commun. 50 (2014) 5156-5170.
42. L.-J. Chen, G.-Z. Zhao, B. Jiang, B. Sun, M. Wang, L. Xu, J. He, Z. Abliz, H. Tan, X. Li, H.-B. Yang, Smart stimuli-responsive spherical nanostructures constructed from supramolecular metallodendrimers via hierarchical self-Assembly, J. Am. Chem. Soc. 136 (2014) 5993-6001.
43. M. Galan, J. Sanchez Rodríguez, M. Cangiotti, S. García-Gallego, J.L. Jimenez, R. Gomez, M.F. Ottaviani, M.A. Muñoz-Fernandez, F.J. de la Mata, Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization, Cur. Med. Chem. 19 (2012) 4984-4994.
44. S. García-Gallego, M.J. Serramía, E. Arnaiz, L. Díaz, M.A. Muñoz-Fernandez, P. Gomez-Sal, M.F. Ottaviani, R. Gomez, F.J. de la Mata, Transition-metal complexes based on a sulfonate-containing N-donor ligand and their use as HIV antiviral agents, Eur. J. Inorg. Chem. (2011) 1657-1665.
45. S. García-Gallego, J. Sanchez Rodríguez, J.L. Jimenez, M. Cangiotti, M.F. Ottaviani, M.A. Muñoz-Fernandez, R. Gomez, F.J. de la Mata, Polyanionic N-donor ligands as chelating agents in transition metal complexes: synthesis, structural characterization and antiviral properties against HIV, Dalton Trans. 41 (2012) 6488-6499.
46. S. García-Gallego, M. Cangiotti, L. Fiorani, A. Fattori, M.A. Muñoz-Fernandez, R. Gomez, M.F. Ottaviani, F.J. de la Mata, Anionic sulfonated and carboxylated PPI dendrimers with EDA core: synthesis and characterization as selective metal complexing agents, Dalton Trans. 42 (2013) 5874-5889.
47. I. García-Merino, N. de Las Cuevas, J.L. Jimenez, J. Gallego, C. Gomez, C. Prieto, M.J. Serramia, R. Lorente, M.A. Muñoz-Fernandez, The spanish HIV BioBank: a model of cooperative HIV research, Retrovirology 6 (2009) 27.
48. H. Saïdi, G. Magri, N. Nasreddine, M. Requena, L. Belec, R5-And X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission, Virology 358 (2007) 55-68.
49. E. De Clercq, Timeline: the bicyclam AMD3100 story, Nat. Rev. Drug Discov. 2 (2003) 581.
50. C. Verhofstede, M. Nijhuis, L. Vandekerckhove, Correlation of coreceptor usage and disease progression, Curr. Opin. HIV AIDS 7 (2012) 432-439.
51. A.N. Vzorov, D. Bhattacharyya, L.G. Marzilli, R.W. Compans, Prevention of HIV-1 infection by platinum triazines, Antivir. Res. 65 (2005) 57-67.